Generic Drug Industry in Asia Countries: Market Research Reports, Statistics and Analysis

Company Report: Generic Drug In South Korea For Year 2013

... Accounted for 15.1% Of the generic drug market (as of 4q12), followed by cj (13.5%), Hanmi (4.7%), Shinpoong (4.0%), And ilong (3.2%). Recommend yuhan as top pick; ckd maintained as second-preferred stock ...

Teva Pharmaceutical Industries Ltd. - Company Report For Year 201 ...

... Issuer rating of a-, with a stable outlook. The credit rating agency said that the rating reflects teva S strategic position as the world's largest generic drug manufactu, financial discipline ...

Company Report: Generic Drug In Singapore, South Korea And The Un ...

Glenmark Pharmaceuticals Ltd. - Company Report For Year 2013

Company Report: Generic Drug In India For Year 2013

Company Report: Generic Drug In India For Year 2013

... And the industry would revert to a growth of 13-14% over the medium-term as structural growth drivers remain intact. The government S pro-generic initiatives may not also impact the industry structure at least ...

Company Report: Generic Drug In India For Year 2013

... The has been widely hailed as a victory for domestic manufactus, particularly generic drug producers. generic drugs are those that are introduced after patents expire on their original formulations ...

Generic Drug Sector In China

... Or manufacturing differences in biologics can result in significant safety differences in and/or effectiveness. Thirdly, the physician and patient should make treatment s. Small molecule generic drugs can ...

The Indonesian Generic Drug Business : Innovation And Technology ...

... A positive impact to the development of indofarma S non-generic drugs. Indofarma wants to increase non-generic drug sales by 20%, such as nutritional, herbal, otc, and anesthesia products. Person quoted ...